Antigua and Barbuda vs Mus: Previously treated cases tested for RR-/MDR-TB (%)
Antigua and Barbuda
100.0%
in 2022
Mus
100.0%
in 2022
Antigua and Barbuda rank
1st
Mus rank
1st
Previously treated cases tested for RR-/MDR-TB (%) over time
- Antigua and Barbuda
- Mus
How they compare
Antigua and Barbuda currently reports 100.0% against 100.0% in Mus, a difference of 0.0%.
Across all 5 years both countries report, Mus has been ahead every year.
Antigua and Barbuda ranks 1st and Mus ranks 1st of 180 countries.
Mus has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Antigua and Barbuda | Mus | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.0% | 100.0% | 50.0% | Mus |
| 2010s | 0.0% | 100.0% | 100.0% | Mus |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Antigua and Barbuda or Mus?
- Antigua and Barbuda, at 100.0% against 100.0% in Mus as of 2022.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Antigua and Barbuda and Mus?
- 0.0%, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and Mus?
- 5 years are reported by both, from 2009 to 2022.
- How do Antigua and Barbuda and Mus rank globally for previously treated cases tested for rr-/mdr-tb?
- Antigua and Barbuda ranks 1st and Mus ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.